These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3905319)

  • 21. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.
    Madle S; Obe G
    Hum Genet; 1980; 56(1):7-20. PubMed ID: 7009387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating computational methods to predict mutagenicity of aromatic azo compounds.
    Gadaleta D; Porta N; Vrontaki E; Manganelli S; Manganaro A; Sello G; Honma M; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Oct; 35(4):239-257. PubMed ID: 29027864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolism of xenobiotics to reactive electrophiles in chemical carcinogenesis and mutagenesis: a collaboration with Elizabeth Cavert Miller and our associates.
    Miller JA
    Drug Metab Rev; 1998 Nov; 30(4):645-74. PubMed ID: 9844805
    [No Abstract]   [Full Text] [Related]  

  • 24. Disperse Yellow 3.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():149-59. PubMed ID: 2197457
    [No Abstract]   [Full Text] [Related]  

  • 25. The interpretation of bacterial mutation tests with azo dyes.
    Combes RD
    Mutat Res; 1981 Mar; 91(2):153-4. PubMed ID: 7254228
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of modifying structure on electrophilic reactions with biological nucleophiles.
    Coles B
    Drug Metab Rev; 1984-1985; 15(7):1307-34. PubMed ID: 6398776
    [No Abstract]   [Full Text] [Related]  

  • 27. Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen.
    Dipple A; Lawley PD; Brookes P
    Eur J Cancer (1965); 1968 Oct; 4(5):493-506. PubMed ID: 5760730
    [No Abstract]   [Full Text] [Related]  

  • 28. Some aspects of metabolism and mutagenicity of o-tolidine and an o-tolidine-based azo dye.
    Tanaka K; Mii T; Marui S; Matsubara I; Igaki H
    Ind Health; 1982; 20(3):227-35. PubMed ID: 7174377
    [No Abstract]   [Full Text] [Related]  

  • 29. On the mutagenicity of tartrazine (FD&C Yellow No 5).
    Combes RD
    Arch Toxicol; 1986 May; 59(1):68-70. PubMed ID: 3741148
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions of azodye carcinogens and azodye carcinogen conjugates with specific proteins in the rat liver.
    Ketterer B; Beale D; Litwack G; Hackney JF
    Chem Biol Interact; 1971 Aug; 3(4):285-6. PubMed ID: 5133002
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism and activation of chemical carcinogens.
    Weisburger EK
    Mol Cell Biochem; 1980 Sep; 32(2):95-104. PubMed ID: 6161301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comutagenicity, competitive enzyme substrates, and in vitro carcinogenicity assays.
    Ashby J; Styles JA
    Mutat Res; 1978 Aug; 54(1):105-12. PubMed ID: 97523
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural alerts to genotoxicity: the interaction of human and artificial intelligence.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1990 Jul; 5(4):333-61. PubMed ID: 2398817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis of the mutagenicity of phenylazoaniline dyes.
    Rosenkranz HS; Klopman G
    Mutat Res; 1989 Nov; 221(3):217-34. PubMed ID: 2811918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of activity of amaranth (FD & C red no. 2) in the Salmonella/microsome mutagenicity test.
    Leconinte P; Lesca P
    Food Cosmet Toxicol; 1978 Feb; 16(1):89-90. PubMed ID: 631667
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of environmental carcinogens: a strategy for the mid-1980s.
    Rosenkranz HS; Klopman G; Chankong V; Pet-Edwards J; Haimes YY
    Environ Mutagen; 1984; 6(2):231-58. PubMed ID: 6546717
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro tests to detect chemical carcinogens.
    Garner RC
    Proc Nutr Soc; 1981 Jan; 40(1):75-85. PubMed ID: 7010359
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term low-dose mutation studies in human cells: metanil yellow and orange II.
    Rastogi PB; Thilly WG; Shirnamé-Moré L
    Mutat Res; 1991 Jul; 249(1):265-73. PubMed ID: 2067539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of mutagenicity tests in chemical carcinogenesis.
    Bartsch H
    Mutat Res; 1976 Jun; 38(3):177-90. PubMed ID: 934170
    [No Abstract]   [Full Text] [Related]  

  • 40. [Natural carcinogens: aglycon-methylazoxymethanol in cycasin].
    Matsumoto H
    Nihon Rinsho; 1972 Apr; 30(4):925-6. PubMed ID: 4672765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.